Hospital
Decatur County Memorial Hospital
Decatur County Memorial Hospital was paid $8.20M by Medicaid between Jan 2018 and Nov 2024, across 100 billing codes. Its largest line is 99284, emergency room visit (serious) — 27% of everything it billed.
33Billing provider infoDECATUR COUNTY MEMORIAL HOSPITAL
GREENSBURG, IN 47240
GREENSBURG, IN 47240
33aNPI1952300477assigned 07/18/2005
33bProvider typeCritical Access Hospital
28Total paid$8.20M
24GClaims227,490
24DCodes billed100
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#4 of 26
Median peer was paid$4.16M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,357 | $296K | |
| 2019 | 27,546 | $761K | |
| 2020 | 26,122 | $966K | |
| 2021 | 34,630 | $1.43M | |
| 2022 | 46,170 | $1.83M | |
| 2023 | 41,225 | $1.84M | |
| 2024incomplete | 24,440 | $1.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 18,798 | 14,084 | $2.19M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 17,351 | 13,819 | $2.11M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 14% | 7,667 | 6,534 | $1.12M |
| 71045 | Radiologic examination, chest; single view | 6.7% | 8,133 | 4,120 | $550K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.6% | 6,393 | 4,386 | $297K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.2% | 2,177 | 1,877 | $183K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.0% | 2,939 | 2,465 | $167K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.0% | 2,538 | 2,082 | $162K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 31,697 | 22,507 | $159K |
| 80053 | Comprehensive metabolic panel | 1.9% | 22,219 | 16,317 | $158K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 49,807 | 34,944 | $129K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.5% | 335 | 79 | $120K |
88 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.4% | 2,529 | $118K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 2,658 | $105K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.1% | 1,625 | $88K |
| 64493 | <1% | 81 | $61K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,318 | $45K |
| 99285 | Emergency room visit (most serious) | <1% | 1,213 | $37K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 383 | $29K |
| 84484 | <1% | 4,497 | $28K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,200 | $28K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 922 | $27K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 169 | $21K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,427 | $18K |
| 81001 | <1% | 7,487 | $18K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 272 | $17K |
| 80061 | Lipid panel | <1% | 2,169 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 595 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 344 | $14K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 817 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,760 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 42 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 235 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 136 | $11K |
| 87634 | <1% | 177 | $9K | |
| 94760 | <1% | 79 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 902 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 200 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 200 | $6K |
| 83690 | <1% | 1,293 | $5K | |
| 73630 | <1% | 167 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 28 | $4K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 22 | $3K |
| 92567 | <1% | 86 | $3K | |
| 97597 | <1% | 49 | $3K | |
| 80076 | <1% | 568 | $3K | |
| 87481 | <1% | 41 | $3K | |
| 85730 | <1% | 577 | $3K | |
| 83721 | <1% | 1,088 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 59 | $2K |
| 85610 | <1% | 739 | $2K | |
| 83605 | <1% | 470 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 30 | $2K |
| 82728 | <1% | 391 | $2K | |
| 83735 | <1% | 804 | $2K | |
| 82550 | <1% | 1,002 | $2K | |
| 71250 | <1% | 30 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 395 | $1K |
| 82553 | <1% | 896 | $1K | |
| 83550 | <1% | 390 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 41 | $1K |
| 83880 | <1% | 108 | $1K | |
| 83540 | <1% | 411 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 56 | $990.52 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 92 | $842.89 |
| 84439 | <1% | 126 | $736.68 | |
| 87510 | <1% | 41 | $726.23 | |
| 82607 | <1% | 138 | $683.02 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 43 | $667.80 |
| 81025 | <1% | 120 | $643.64 | |
| 94010 | <1% | 12 | $605.36 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 259 | $591.74 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 16 | $531.35 |
| 82746 | <1% | 126 | $514.44 | |
| 82150 | <1% | 164 | $486.91 | |
| 84703 | <1% | 84 | $463.18 | |
| 85379 | <1% | 37 | $289.04 | |
| 99443 | <1% | 52 | $288.94 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $240.80 |
| 82043 | <1% | 74 | $211.88 | |
| 86803 | <1% | 13 | $142.70 | |
| Q3014 | Telehealth originating site facility fee | <1% | 33 | $133.46 |
| 81003 | <1% | 142 | $96.85 | |
| 82570 | <1% | 33 | $67.34 | |
| 85027 | <1% | 12 | $51.76 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 321 | $17.86 |
| A0425 | Ground mileage, per statute mile | 0% | 2,755 | $0.00 |
| A0429 | Emergency ambulance ride, basic life support | 0% | 121 | $0.00 |
| 91300 | 0% | 21 | $0.00 | |
| 90662 | 0% | 18 | $0.00 | |
| 3078F | 0% | 18 | $0.00 | |
| 11721 | 0% | 28 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 19 | $0.00 |
| A0427 | Emergency ambulance ride, advanced life support | 0% | 1,138 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 32 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 93 | $0.00 |
| 0001A | 0% | 23 | $0.00 | |
| 3074F | 0% | 16 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUCKEL, MICHAEL (VP OF FINANCE)